113
Views
21
CrossRef citations to date
0
Altmetric
Original

Case Series of Buprenorphine Injectors in Kuala Lumpur, Malaysia

, M.D., M.A., , B.A., , M.A., , M.D., , M.D. & , M.D.
Pages 511-517 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Shan-Estelle Brown, Jeffrey A. Wickersham, Alyssa R. Pelletier, Ruthanne M. Marcus, Rebecca Erenrich, Adeeba Kamarulzaman & Frederick L. Altice. (2017) Attitudes toward medication-assisted treatment among fishermen in Kuantan, Malaysia, who inject drugs. Journal of Ethnicity in Substance Abuse 16:3, pages 363-379.
Read now
Jeffrey A. Wickersham, Kelsey B. Loeliger, Ruthanne Marcus, Veena Pillai, Adeeba Kamarulzaman & Frederick L. Altice. (2016) Patterns of substance use and correlates of lifetime and active injection drug use among women in Malaysia. The American Journal of Drug and Alcohol Abuse 42:1, pages 98-110.
Read now
Ali S. Saber-Tehrani, Robert Douglas Bruce & Frederick L. Altice. (2011) Pharmacokinetic drug interactions and adverse consequences between psychotropic medications and pharmacotherapy for the treatment of opioid dependence. The American Journal of Drug and Alcohol Abuse 37:1, pages 1-11.
Read now
Shannon Gwin Mitchell, Sharon M. Kelly, Barry S. Brown, Heather Schacht Reisinger, James A. Peterson, Adrienne Ruhf, Michael H. Agar, Kevin E. O'Grady & Robert P. Schwartz. (2009) Uses of Diverted Methadone and Buprenorphine by Opioid-Addicted Individuals in Baltimore, Maryland. American Journal on Addictions 18:5, pages 346-355.
Read now
R. Douglas Bruce, Sumathi Govindasamy, Laurie Sylla, Adeeba Kamarulzaman & Frederick L. Altice. (2009) Lack of Reduction in Buprenorphine Injection After Introduction of Co-Formulated Buprenorphine/Naloxone to the Malaysian Market. The American Journal of Drug and Alcohol Abuse 35:2, pages 68-72.
Read now

Articles from other publishers (16)

Nikki Bozinoff, Vitor Soares Tardelli, Dafna Sara Rubin-Kahana & Bernard Le Foll. (2022) Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review. Harm Reduction Journal 19:1.
Crossref
Abhimanyu Sud, Fabio Salamanca-Buentello, Daniel Z. Buchman, Pamela Sabioni & Umair Majid. (2022) Beyond harm-producing versus harm-reducing: A qualitative meta-synthesis of people who use drugs' perspectives of and experiences with the extramedical use and diversion of buprenorphine. Journal of Substance Abuse Treatment 135, pages 108651.
Crossref
Charurut Somboonwit, Lianet Vazquez & Lynette J. Menezes. 2019. Global Virology III: Virology in the 21st Century. Global Virology III: Virology in the 21st Century 423 436 .
Ali Ghaddar, Sanaa Khandaqji & Zeinab Abbass. (2018) Challenges in implementing opioid agonist therapy in Lebanon: a qualitative study from a user’s perspective. Substance Abuse Treatment, Prevention, and Policy 13:1.
Crossref
Gabriel J. Culbert, Veena Pillai, Joseph Bick, Haider A. Al-Darraji, Jeffrey A. Wickersham, Martin P. Wegman, Alexander R. Bazazi, Enrico Ferro, Michael Copenhaver, Adeeba Kamarulzaman & Frederick L. Altice. (2016) Confronting the HIV, Tuberculosis, Addiction, and Incarceration Syndemic in Southeast Asia: Lessons Learned from Malaysia. Journal of Neuroimmune Pharmacology 11:3, pages 446-455.
Crossref
Chethan Bachireddy, Daniel F. Weisberg & Frederick L. Altice. (2015) Balancing access and safety in prescribing opioid agonist therapy to prevent HIV transmission. Addiction 110:12, pages 1869-1871.
Crossref
Essiina Launonen, Hannu Alho, Elina Kotovirta, Isla Wallace & Kaarlo Simojoki. (2015) Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patients. International Journal of Drug Policy 26:9, pages 875-882.
Crossref
Aishwarya Vijay, Alexander R. Bazazi, Ilias Yee, Adeeba Kamarulzaman & Frederick L. Altice. (2015) Treatment Readiness, Attitudes Toward, and Experiences with Methadone and Buprenorphine Maintenance Therapy Among People Who Inject Drugs in Malaysia. Journal of Substance Abuse Treatment 54, pages 29-36.
Crossref
B. Vicknasingam, M.N.M. Dazali, D. Singh, R.S. Schottenfeld & M.C. Chawarski. (2015) Buprenorphine/naloxone treatment practices in Malaysia: Results of national surveys of physicians and patients. Drug and Alcohol Dependence 152, pages 164-169.
Crossref
Kanna Hayashi, Paisan Suwannawong, Lianping Ti, Karyn Kaplan, Evan Wood & Thomas Kerr. (2013) High rates of midazolam injection and associated harms in B angkok, T hailand . Addiction 108:5, pages 944-952.
Crossref
Jermaine D. Jones, Shanthi Mogali & Sandra D. Comer. (2012) Polydrug abuse: A review of opioid and benzodiazepine combination use. Drug and Alcohol Dependence 125:1-2, pages 8-18.
Crossref
Raminta Daniulaityte, Russel Falck & Robert G. Carlson. (2012) Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids. Drug and Alcohol Dependence 122:3, pages 201-207.
Crossref
Chethan Bachireddy, Alexander R. Bazazi, Ravi Kavasery, Sumathi Govindasamy, Adeeba Kamarulzaman & Frederick L. Altice. (2011) Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: Implications for secondary prevention. Drug and Alcohol Dependence 116:1-3, pages 151-157.
Crossref
Pria Anand, Sandra A. Springer, Michael M. Copenhaver & Frederick L. Altice. (2010) Neurocognitive Impairment and HIV Risk Factors: A Reciprocal Relationship. AIDS and Behavior 14:6, pages 1213-1226.
Crossref
Shannon Gwin Mitchell, Sharon M. Kelly, Barry S. Brown, Heather Schacht Reisinger, James A. Peterson, Adrienne Ruhf, Michael H. Agar, Kevin E. O'Grady & Robert P. Schwartz. (2010) Uses of Diverted Methadone and Buprenorphine by Opioid‐Addicted Individuals in Baltimore, Maryland. The American Journal on Addictions 18:5, pages 346-355.
Crossref
C. N. E. Tompkins, N. M. J. Wright, M. G. Waterman & L. Sheard. (2009) Exploring prison buprenorphine misuse in the United Kingdom: A qualitative study of former prisoners. International Journal of Prisoner Health 5:2, pages 71-87.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.